Last reviewed · How we verify
IL-YANG Flu Vaccine Prefilled Syringe
IL-YANG Flu Vaccine Prefilled Syringe is a Inactivated influenza vaccine Biologic drug developed by Il-Yang Pharm. Co., Ltd.. It is currently in Phase 3 development for Seasonal influenza prevention in adults and/or pediatric populations.
IL-YANG Flu Vaccine stimulates the immune system to produce antibodies and cellular immunity against influenza virus strains included in the vaccine formulation.
IL-YANG Flu Vaccine stimulates the immune system to produce antibodies and cellular immunity against influenza virus strains included in the vaccine formulation. Used for Seasonal influenza prevention in adults and/or pediatric populations.
At a glance
| Generic name | IL-YANG Flu Vaccine Prefilled Syringe |
|---|---|
| Sponsor | Il-Yang Pharm. Co., Ltd. |
| Drug class | Inactivated influenza vaccine |
| Modality | Biologic |
| Therapeutic area | Immunology |
| Phase | Phase 3 |
Mechanism of action
As an inactivated influenza vaccine in prefilled syringe form, it contains antigens from seasonal flu virus strains that trigger both humoral (antibody) and cell-mediated immune responses. This prepares the immune system to recognize and rapidly neutralize circulating influenza viruses, reducing infection risk and disease severity.
Approved indications
- Seasonal influenza prevention in adults and/or pediatric populations
Common side effects
- Injection site pain, redness, or swelling
- Myalgia (muscle pain)
- Headache
- Fatigue
- Low-grade fever
Key clinical trials
- Phase 3 Study to Evaluate the Immunogenicity and Safety of Inactived Split Influenza Vaccine in Healthy Korea Infants (PHASE3)
- Study to Evaluate the Immunogenicity and Safety of 'IL-YANG Quadrivalent Influenza Vaccine Inj.' (PHASE3)
- Phase 3 Study to Evaluate the Immunogenicity and Safety of Inactivated Split Influenza Vaccine in Healthy Korea Children (PHASE3)
- Phase 1 Study to Assess the Safety of Inactivated Split Influenza Vaccine and Control Vaccine in Korean Volunteer (PHASE1)
- Phase 3 Study to Evaluate the Immunogenicity and Safety of Inactivated Split Influenza Vaccine in Healthy Korea Adults (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- IL-YANG Flu Vaccine Prefilled Syringe CI brief — competitive landscape report
- IL-YANG Flu Vaccine Prefilled Syringe updates RSS · CI watch RSS
- Il-Yang Pharm. Co., Ltd. portfolio CI
Frequently asked questions about IL-YANG Flu Vaccine Prefilled Syringe
What is IL-YANG Flu Vaccine Prefilled Syringe?
How does IL-YANG Flu Vaccine Prefilled Syringe work?
What is IL-YANG Flu Vaccine Prefilled Syringe used for?
Who makes IL-YANG Flu Vaccine Prefilled Syringe?
What drug class is IL-YANG Flu Vaccine Prefilled Syringe in?
What development phase is IL-YANG Flu Vaccine Prefilled Syringe in?
What are the side effects of IL-YANG Flu Vaccine Prefilled Syringe?
Related
- Drug class: All Inactivated influenza vaccine drugs
- Manufacturer: Il-Yang Pharm. Co., Ltd. — full pipeline
- Therapeutic area: All drugs in Immunology
- Indication: Drugs for Seasonal influenza prevention in adults and/or pediatric populations
- Compare: IL-YANG Flu Vaccine Prefilled Syringe vs similar drugs
- Pricing: IL-YANG Flu Vaccine Prefilled Syringe cost, discount & access